DOI:
10.1055/s-00000135
Deutsche Heilpraktiker-Zeitschrift
LinksClose Window
References
Saposnik G, Ray JG, Sheridan P et al.
Heart Outcomes Prevention Evaluation 2 Investigators. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
Stroke 2009;
40 (4) 1365-372
We do not assume any responsibility for the contents of the web pages of other providers.